Collplant Biotechnologies Ltd
NASDAQ:CLGN
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
3.41
6.75
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Collplant Biotechnologies Ltd
Operating Expenses
Collplant Biotechnologies Ltd
Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Operating Expenses
-$16.5m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
||
Kamada Ltd
NASDAQ:KMDA
|
Operating Expenses
-$49.6m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-6%
|
||
Enlivex Therapeutics Ltd
NASDAQ:ENLV
|
Operating Expenses
-$18.7m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
||
Urogen Pharma Ltd
NASDAQ:URGN
|
Operating Expenses
-$164.4m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
||
Entera Bio Ltd
NASDAQ:ENTX
|
Operating Expenses
-$7.2m
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
||
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Operating Expenses
-â‚Ş29.8m
|
CAGR 3-Years
19%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-10%
|
Collplant Biotechnologies Ltd
Glance View
CollPlant Biotechnologies Ltd. is a regenerative medicine company, which engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
See Also
What is Collplant Biotechnologies Ltd's Operating Expenses?
Operating Expenses
-16.5m
USD
Based on the financial report for Dec 31, 2023, Collplant Biotechnologies Ltd's Operating Expenses amounts to -16.5m USD.
What is Collplant Biotechnologies Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-17%
Over the last year, the Operating Expenses growth was 3%. The average annual Operating Expenses growth rates for Collplant Biotechnologies Ltd have been -24% over the past three years , -17% over the past five years .